IOL CHEMICALS & PHARM. | GUJ.THEMIS. | IOL CHEMICALS & PHARM./ GUJ.THEMIS. |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 13.6 | 53.9 | 25.1% | View Chart |
P/BV | x | 1.5 | 19.9 | 7.8% | View Chart |
Dividend Yield | % | 1.0 | 0.3 | 381.5% |
IOL CHEMICALS & PHARM. GUJ.THEMIS. |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
IOL CHEMICALS & PHARM. Mar-23 |
GUJ.THEMIS. Mar-23 |
IOL CHEMICALS & PHARM./ GUJ.THEMIS. |
5-Yr Chart Click to enlarge
|
||
High | Rs | 537 | 921 | 58.3% | |
Low | Rs | 272 | 376 | 72.4% | |
Sales per share (Unadj.) | Rs | 377.6 | 102.5 | 368.3% | |
Earnings per share (Unadj.) | Rs | 23.7 | 39.9 | 59.4% | |
Cash flow per share (Unadj.) | Rs | 31.6 | 41.7 | 75.7% | |
Dividends per share (Unadj.) | Rs | 4.00 | 1.08 | 370.4% | |
Avg Dividend yield | % | 1.0 | 0.2 | 593.9% | |
Book value per share (Unadj.) | Rs | 256.8 | 102.6 | 250.2% | |
Shares outstanding (eoy) | m | 58.71 | 14.53 | 404.1% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.1 | 6.3 | 16.9% | |
Avg P/E ratio | x | 17.1 | 16.3 | 105.0% | |
P/CF ratio (eoy) | x | 12.8 | 15.6 | 82.3% | |
Price / Book Value ratio | x | 1.6 | 6.3 | 24.9% | |
Dividend payout | % | 16.9 | 2.7 | 623.5% | |
Avg Mkt Cap | Rs m | 23,743 | 9,423 | 252.0% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 1,682 | 77 | 2,171.3% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 22,171 | 1,490 | 1,488.3% | |
Other income | Rs m | 256 | 60 | 425.1% | |
Total revenues | Rs m | 22,427 | 1,550 | 1,446.9% | |
Gross profit | Rs m | 2,257 | 742 | 304.1% | |
Depreciation | Rs m | 462 | 26 | 1,791.9% | |
Interest | Rs m | 165 | 2 | 8,194.0% | |
Profit before tax | Rs m | 1,887 | 775 | 243.5% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 495 | 195 | 253.9% | |
Profit after tax | Rs m | 1,391 | 580 | 240.0% | |
Gross profit margin | % | 10.2 | 49.8 | 20.4% | |
Effective tax rate | % | 26.2 | 25.2 | 104.3% | |
Net profit margin | % | 6.3 | 38.9 | 16.1% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 9,667 | 813 | 1,189.4% | |
Current liabilities | Rs m | 5,025 | 357 | 1,407.6% | |
Net working cap to sales | % | 20.9 | 30.6 | 68.4% | |
Current ratio | x | 1.9 | 2.3 | 84.5% | |
Inventory Days | Days | 43 | 128 | 33.8% | |
Debtors Days | Days | 8 | 439 | 1.9% | |
Net fixed assets | Rs m | 11,017 | 1,055 | 1,044.5% | |
Share capital | Rs m | 587 | 73 | 808.2% | |
"Free" reserves | Rs m | 14,490 | 1,419 | 1,021.3% | |
Net worth | Rs m | 15,077 | 1,491 | 1,010.9% | |
Long term debt | Rs m | 0 | 0 | - | |
Total assets | Rs m | 20,684 | 1,868 | 1,107.6% | |
Interest coverage | x | 12.5 | 386.4 | 3.2% | |
Debt to equity ratio | x | 0 | 0 | - | |
Sales to assets ratio | x | 1.1 | 0.8 | 134.4% | |
Return on assets | % | 7.5 | 31.1 | 24.2% | |
Return on equity | % | 9.2 | 38.9 | 23.7% | |
Return on capital | % | 13.6 | 52.1 | 26.1% | |
Exports to sales | % | 26.7 | 0 | - | |
Imports to sales | % | 0 | 1.7 | 0.0% | |
Exports (fob) | Rs m | 5,930 | NA | - | |
Imports (cif) | Rs m | NA | 25 | 0.0% | |
Fx inflow | Rs m | 5,930 | 0 | - | |
Fx outflow | Rs m | 6,052 | 25 | 24,284.9% | |
Net fx | Rs m | -122 | -25 | 488.4% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 1,223 | 395 | 309.5% | |
From Investments | Rs m | -1,200 | -204 | 588.0% | |
From Financial Activity | Rs m | -41 | -133 | 30.9% | |
Net Cashflow | Rs m | -18 | 58 | -31.8% |
Indian Promoters | % | 48.2 | 70.9 | 68.0% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 1.7 | 1.9 | 90.9% | |
FIIs | % | 1.4 | 1.1 | 133.3% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 51.8 | 29.1 | 177.8% | |
Shareholders | 130,003 | 29,576 | 439.6% | ||
Pledged promoter(s) holding | % | 0.0 | 3.3 | - |
Compare IOL CHEMICALS & PHARM. With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB MANKIND PHARMA
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | IOL CHEMICALS & PHARM. | GUJ.THEMIS. | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | -0.80% | -0.12% | 0.34% |
1-Month | 4.69% | 6.05% | 0.25% |
1-Year | -3.18% | -45.22% | 54.31% |
3-Year CAGR | -13.27% | 19.54% | 15.04% |
5-Year CAGR | 17.19% | 58.94% | 19.87% |
* Compound Annual Growth Rate
Here are more details on the IOL CHEMICALS & PHARM. share price and the GUJ.THEMIS. share price.
Moving on to shareholding structures...
The promoters of IOL CHEMICALS & PHARM. hold a 48.2% stake in the company. In case of GUJ.THEMIS. the stake stands at 70.9%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of IOL CHEMICALS & PHARM. and the shareholding pattern of GUJ.THEMIS..
Finally, a word on dividends...
In the most recent financial year, IOL CHEMICALS & PHARM. paid a dividend of Rs 4.0 per share. This amounted to a Dividend Payout ratio of 16.9%.
GUJ.THEMIS. paid Rs 1.1, and its dividend payout ratio stood at 2.7%.
You may visit here to review the dividend history of IOL CHEMICALS & PHARM., and the dividend history of GUJ.THEMIS..
For a sector overview, read our pharmaceuticals sector report.
After opening the day on positive note, Indian share markets continued the momentum as the session progressed and ended on firm footing.